Redhill Biopharma Ltd. ADR (NASDAQ:RDHL) has a beta value of 4.39 and has seen 0.58 million shares traded in the recent trading session. The company, currently valued at $3.44M, closed the recent trade at $2.71 per share which meant it lost -$0.08 on the day or -2.87% during that session. The RDHL stock price is -647.97% off its 52-week high price of $20.27 and -2.95% below the 52-week low of $2.79. If we look at the company’s 10-day average daily trading volume, we find that it stood at 37670.0 shares traded. The 3-month trading volume is 57.10K shares.

Redhill Biopharma Ltd. ADR (NASDAQ:RDHL) trade information

Sporting -2.87% in the red today, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the RDHL stock price touched $2.71 or saw a rise of 21.9%. Year-to-date, Redhill Biopharma Ltd. ADR shares have moved -56.36%, while the 5-day performance has seen it change -18.74%. Over the past 30 days, the shares of Redhill Biopharma Ltd. ADR (NASDAQ:RDHL) have changed -51.52%. Short interest in the company has seen 33975.0 shares shorted with days to cover at 0.28.

RDHL Dividends

Redhill Biopharma Ltd. ADR is expected to release its next earnings report on 2022-Nov-06 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.

Redhill Biopharma Ltd. ADR (NASDAQ:RDHL)’s Major holders

Investors are also buoyed by the number of investors in a company, with Redhill Biopharma Ltd. ADR having a total of 16.0 institutions that hold shares in the company.